![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Frampton James E.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.70, Iss.17, 2010-12, pp. : 2289-2313
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Long-Acting Risperidone: A Review of Its Use in Schizophrenia
By Tracy Swainston Harrison Goa K.L.
CNS Drugs, Vol. 18, Iss. 2, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Octreotide Long-Acting Release (LAR): A Review of its Use in the Management of Acromegaly
By McKeage K. Cheer S. Wagstaff A.J.
Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. :